Reuters logo
India's Sun Pharma fourth-quarter profit down 13.6 pct
May 26, 2017 / 11:35 AM / 6 months ago

India's Sun Pharma fourth-quarter profit down 13.6 pct

MUMBAI, May 26 (Reuters) - Sun Pharmaceutical Industries Ltd , India’s largest drugmaker by sales, reported a 13.6 percent drop in its fourth-quarter profit due to slow sales in the United States.

The Mumbai-based company reported a January-March net profit of 12.24 billion rupees ($189.94 million), compared with 14.16 billion rupees a year earlier. This was below an average estimate of 15 billion rupees from 21 analysts polled by Thomson Reuters. ($1 = 64.4400 Indian rupees) (Reporting by Zeba Siddiqui in Mumbai. Editing by Jane Merriman)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below